Literature DB >> 16871421

A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors.

Rosa de Llanos1, M Teresa Fernández-Espinar, Amparo Querol.   

Abstract

Saccharomyces cerevisiae is the most widely used yeast in industrial/commercial food and beverage production and is even consumed as a nutritional supplement. Various cases of fungemia caused by this yeast species in severely debilitated traumatized or immune-deficient patients have been reported in recent years, suggesting that this species could be an opportunistic pathogen in such patients. To determine whether the industrial S. cerevisiae strains can be included in this virulent group of strains, we carried out a comparative study between clinical and industrial yeasts based on the various phenotypic traits associated with pathogenicity in two other yeast species (Candida albicans and Cryptococcus neoformans). The majority of the clinical isolates were found to secrete higher levels of protease and phospholipase, grow better at 42 degrees C and show strong pseudohyphal growth relative to industrial yeasts. However three industrial yeast strains, one commercial wine strain, baker's yeast and one commercial strain of S. cerevisiae (var. boulardii), were exceptions and based on their physiological traits these yeasts would appear to be related to clinical strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871421     DOI: 10.1007/s10482-006-9077-7

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  15 in total

1.  Genome-wide association analysis of clinical vs. nonclinical origin provides insights into Saccharomyces cerevisiae pathogenesis.

Authors:  L A H Muller; J E Lucas; D R Georgianna; J H McCusker
Journal:  Mol Ecol       Date:  2011-08-31       Impact factor: 6.185

2.  Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth.

Authors:  J Zupan; Z Tomičić; P Raspor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-27       Impact factor: 3.267

3.  Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata.

Authors:  Monika Batova; Silvia Borecka-Melkusova; Maria Simockova; Vladimira Dzugasova; Eduard Goffa; Julius Subik
Journal:  Curr Genet       Date:  2008-03-15       Impact factor: 3.886

4.  Comparative genomic analysis reveals a critical role of de novo nucleotide biosynthesis for Saccharomyces cerevisiae virulence.

Authors:  Roberto Pérez-Torrado; Silvia Llopis; Benedetta Perrone; Rocío Gómez-Pastor; Bernhard Hube; Amparo Querol
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

5.  Transcriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strains.

Authors:  Silvia Llopis; Amparo Querol; Antje Heyken; Bernhard Hube; Lene Jespersen; M Teresa Fernández-Espinar; Roberto Pérez-Torrado
Journal:  BMC Genomics       Date:  2012-08-23       Impact factor: 3.969

6.  Comparative genomics of wild type yeast strains unveils important genome diversity.

Authors:  Laura Carreto; Maria F Eiriz; Ana C Gomes; Patrícia M Pereira; Dorit Schuller; Manuel A S Santos
Journal:  BMC Genomics       Date:  2008-11-04       Impact factor: 3.969

7.  Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits.

Authors:  Trine Danø Klingberg; Urska Lesnik; Nils Arneborg; Peter Raspor; Lene Jespersen
Journal:  FEMS Yeast Res       Date:  2008-03-18       Impact factor: 2.796

8.  Pathogenic potential of Saccharomyces strains isolated from dietary supplements.

Authors:  Silvia Llopis; Carolina Hernández-Haro; Lucía Monteoliva; Amparo Querol; María Molina; María T Fernández-Espinar
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

9.  Whole Genome Analysis of 132 Clinical Saccharomyces cerevisiae Strains Reveals Extensive Ploidy Variation.

Authors:  Yuan O Zhu; Gavin Sherlock; Dmitri A Petrov
Journal:  G3 (Bethesda)       Date:  2016-08-09       Impact factor: 3.154

Review 10.  Opportunistic Strains of Saccharomyces cerevisiae: A Potential Risk Sold in Food Products.

Authors:  Roberto Pérez-Torrado; Amparo Querol
Journal:  Front Microbiol       Date:  2016-01-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.